Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Nakayama

Showing results (31-40 of 174) with videos related to

Pageof 18
Sort By:
Cancer Letters|April 2, 2003
Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatinKentaro Nakayama, Yuji Takebayashi, Satoru Nakayama, et al.
Molecular and Clinical Oncology|August 8, 2017
Bevacizumab plus chemotherapy continued beyond progression in patients with type II endometrial cancer previously treated with bevacizumab plus chemotherapy: A case reportEmi Sato, Kentaro Nakayama, Kohei Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogenMasako Ishibashi, Kentaro Nakayama, Shamima Yeasmin, et al.
Eneurologicalsci|June 30, 2022
Early presentation of lower urinary tract and bowel dysfunction in sporadic amyotrophic lateral sclerosis: A case reportMasataka Nakamura, Kentaro Nakayama, Aya Murakami, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2011
Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinomaIe-Ming Shih, Kentaro Nakayama, Gang Wu, et al.
Molecular and Clinical Oncology|June 23, 2016
Case series of cerebral infarction with Trousseau's syndrome associated with malignant gynecological tumorsMasako Ishikawa, Kentaro Nakayama, Tomoka Ishibashi, et al.
Anticancer Research|August 5, 2003
Induction of thymidine phosphorylase expression and enhancement of Furtulon sensitivity by Taxol in a human ovarian carcinoma cell lineKohkichi Hata, Mitsuhiko Osaki, Haruhiko Kanasaki, et al.
Archives of Biochemistry and Biophysics|July 18, 2016
Protein complex formation and intranuclear dynamics of NAC1 in cancer cellsNaomi Nakayama, Hiroaki Kato, Gyosuke Sakashita, et al.
Anticancer Research|June 25, 2003
Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell lineKohkichi Hata, Mitsuhiko Osaki, Haruhiko Kanasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 24, 2010
[Paclitaxel + carboplatin (TC)-resistant stage Ic squamous cell carcinomas arising in mature cystic teratomas of the ovary]Masako Ishikawa, Kentaro Nakayama, Shamima Yeasmin, et al.
Pageof 18

Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
Cancer Letters|April 2, 2003
Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatinKentaro Nakayama, Yuji Takebayashi, Satoru Nakayama, et al.
Molecular and Clinical Oncology|August 8, 2017
Bevacizumab plus chemotherapy continued beyond progression in patients with type II endometrial cancer previously treated with bevacizumab plus chemotherapy: A case reportEmi Sato, Kentaro Nakayama, Kohei Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogenMasako Ishibashi, Kentaro Nakayama, Shamima Yeasmin, et al.
Eneurologicalsci|June 30, 2022
Early presentation of lower urinary tract and bowel dysfunction in sporadic amyotrophic lateral sclerosis: A case reportMasataka Nakamura, Kentaro Nakayama, Aya Murakami, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2011
Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinomaIe-Ming Shih, Kentaro Nakayama, Gang Wu, et al.
Molecular and Clinical Oncology|June 23, 2016
Case series of cerebral infarction with Trousseau's syndrome associated with malignant gynecological tumorsMasako Ishikawa, Kentaro Nakayama, Tomoka Ishibashi, et al.
Anticancer Research|August 5, 2003
Induction of thymidine phosphorylase expression and enhancement of Furtulon sensitivity by Taxol in a human ovarian carcinoma cell lineKohkichi Hata, Mitsuhiko Osaki, Haruhiko Kanasaki, et al.
Archives of Biochemistry and Biophysics|July 18, 2016
Protein complex formation and intranuclear dynamics of NAC1 in cancer cellsNaomi Nakayama, Hiroaki Kato, Gyosuke Sakashita, et al.
Anticancer Research|June 25, 2003
Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell lineKohkichi Hata, Mitsuhiko Osaki, Haruhiko Kanasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 24, 2010
[Paclitaxel + carboplatin (TC)-resistant stage Ic squamous cell carcinomas arising in mature cystic teratomas of the ovary]Masako Ishikawa, Kentaro Nakayama, Shamima Yeasmin, et al.
Pageof 18